Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lemaitre Vascular (NQ: LMAT ) 90.63 -0.23 (-0.26%) Streaming Delayed Price Updated: 11:44 AM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 13,457 Open 90.14 Bid (Size) 90.43 (1) Ask (Size) 90.80 (4) Prev. Close 90.86 Today's Range 89.67 - 90.80 52wk Range 44.27 - 93.24 Shares Outstanding 22,263,235 Dividend Yield 0.62% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024 August 01, 2024 LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Staar Surgical Stock Earns RS Rating Upgrade June 27, 2024 On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. Via Investor's Business Daily Performance YTD +59.81% +59.81% 1 Month +3.60% +3.60% 3 Month +11.62% +11.62% 6 Month +41.54% +41.54% 1 Year +64.30% +64.30% More News Read More Navigating 4 Analyst Ratings For LeMaitre Vascular May 31, 2024 Via Benzinga Stryker Stock Sees RS Rating Treks Higher To 71 May 29, 2024 Via Investor's Business Daily Sell In May And Go Away? – April Dividend Income Report May 27, 2024 Via Talk Markets LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Recap: LeMaitre Vascular Q4 Earnings February 27, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga A Preview Of LeMaitre Vascular's Earnings February 26, 2024 Via Benzinga 5 Analysts Have This to Say About LeMaitre Vascular October 23, 2023 Via Benzinga Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 April 30, 2024 Via Investor's Business Daily Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know February 28, 2024 Via Benzinga Sidoti Events, LLC's Virtual December Small-Cap Conference December 05, 2023 Via ACCESSWIRE Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating September 06, 2023 Via Benzinga Looking for Dividend Growth? Buy This Little-Known Healthcare Stock September 01, 2023 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 September 06, 2023 Via Benzinga 2 Healthcare Stocks That Could Help Make You a Fortune August 26, 2023 Via The Motley Fool Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year August 23, 2023 Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 August 03, 2023 Via Benzinga Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday August 03, 2023 Via Benzinga 3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential June 28, 2023 Via InvestorPlace Beat the Dow Jones With This Unstoppable Dividend Stock June 19, 2023 Via The Motley Fool Sidoti Events, LLC's Virtual June Small-Cap Conference June 13, 2023 Via ACCESSWIRE Is This Healthcare Stock a Buy for Dividend Growth Investors? May 17, 2023 Via The Motley Fool Why Shares of LeMaitre Vascular Are Up Wednesday May 03, 2023 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
